Innate Pharma SA Increase Through New Leases Liabilities Arising From Financing Activities
Innate Pharma SA (IPHYF) reported Increase Through New Leases Liabilities Arising From Financing Activities of EUR 1.10 million for the 1-month period ending 2020-01-31, per its 20-F filed 2021-04-27.
Discontinued › Cash Flow › Financing Activities
ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities · last filed 2021-04-27
- 2020-01-31: Increase Through New Leases Liabilities Arising From Financing Activities 1 month 1.10M EUR.
| Period end | Increase Through New Leases Liabilities Arising From Financing Activities 1 month |
|---|---|
| 2020-01-31 | 1.10M EUR 20-F · filed 2021-04-27 |